Results 41 to 50 of about 4,127 (170)

Current status of transarterial radioembolization

World Journal of Radiology, 2016
Unresectable primary and secondary liver malignancies present a major problem in the treatment of solid tumors. Transarterial radioembolization (TARE) is an increasingly used technique for treating various types of malignant liver tumors. This approach is appealing, as the mechanism of action is independent from other loco-regional treatments and ...
openaire   +2 more sources

A rare case of replaced right hepatic artery with direct aortic origin described angiographically during trans-arterial radioembolization

Radiology Case Reports
Normal hepatic arterial anatomy consists of the right hepatic artery and left hepatic artery branching from the common hepatic artery. Despite this being the most common configuration, many variations have been described.
Michael Mohnasky, MBS, Lourens Du Pisanie, MD, Jocelyn Mizero, Sandra Gad, Haneyeh Shahbazian, MD, Alex Villalobos, MD, Nima Kokabi, MD   +6 more
doaj   +1 more source

Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver

International Journal of Hepatology, 2011
Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial radioembolization with Yttrium-90- (90Y-) labeled microspheres has been ...
Martin Vyleta, Douglas Coldwell
doaj   +1 more source

Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside

Precision Radiation Oncology, EarlyView.
The dual immunomodulatory network of radiotherapy in hepatocellular carcinoma. Radiotherapy initiates its effects by inducing immunogenic cell death and DNA double‐strand breaks. Immune Activation: Cytosolic DNA from damaged cells activates the cGAS‐STING pathway, triggering IRF3/NF‐κB‐mediated type I interferon production. This enhances dendritic cell
Zhigang Fu, Yang Zhang, Zuomin Wang, Zongjuan Li, Shisuo Du   +4 more
wiley   +1 more source

Management of Satellite Lesions in Hepatocellular Carcinoma: An Updated Review

Journal of Surgical Oncology, Volume 134, Issue 2, Page 157-165, August 2026.
ABSTRACT Satellite lesions, defined as microscopic or small macroscopic tumor nodules within 2 cm of a primary hepatocellular carcinoma (HCC), represent early intrahepatic dissemination and are strongly associated with aggressive tumor biology.
Andy Tran, Mohammed O. Suraju, Ihuoma Tasie, Abdelrahman K. Abdalla, Hassan Aziz   +4 more
wiley   +1 more source

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

PLoS ONE, 2016
Background/aimsLimited treatment options are available for patients with hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Transarterial radioembolization using Yttrium-90 microspheres is a new treatment modality for HCC with PVT.
Young Youn Cho, Minjong Lee, Hyo-Cheol Kim, Jin Wook Chung, Yun Hwan Kim, Geum-Youn Gwak, Si Hyun Bae, Do Young Kim, Jeong Heo, Yoon Jun Kim   +9 more
doaj   +1 more source

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review

Gastroenterology Research and Practice, 2015
Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new patients per year. Curative treatments are available in a small percentage of patients, while most of them present in stages requiring locoregional ...
Daniel Marin, Salvatore Cappabianca, Nicola Serra, Assunta Sica, Francesco Lassandro, Roberto D’Angelo, Michelearcangelo La Porta, Francesco Fiore, Francesco Somma   +8 more
doaj   +1 more source

Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study

JMIR Research Protocols, 2020
BackgroundRadioembolization, also known as transarterial radioembolization or selective internal radiation therapy with yttrium-90 (90Y) resin microspheres, is an established treatment modality for patients with primary and secondary liver tumors ...
Helmberger, Thomas, Arnold, Dirk, Bilbao, José I, de Jong, Niels, Maleux, Geert, Nordlund, Anders, Peynircioglu, Bora, Sangro, Bruno, Sharma, Ricky A, Walk, Agnes   +9 more
doaj   +1 more source

Acute Arteriobiliary Fistula Emergent Long after Biliary Drainage and Radioembolization

Journal of Clinical Interventional Radiology ISVIR, 2022
Various causes of hemobilia have been described in the literature, majority being iatrogenic. Other different pathologies such as inflammation and tumors also have been described.
Murat Dökdök, Kutlay Karaman
doaj   +1 more source

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1701-1721, June 2026.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source